Tagworks Pharmaceuticals is developing a unique approach towards antibody-based imaging and therapy. Tagworks’ technology enables the actuation of tagged antibodies through selective chemical manipulation in vivo, improving the efficacy of established approaches such as Radioimmuno-imaging and –therapy and Antibody-Drug Conjugates.
Location: Netherlands, Gelderland, Nijmegen
Employees: 11-50
Total raised: $65M
Founded date: 2011
Investors 2
| Date | Name | Website |
| 08.07.2023 | Ysios Capi... | ysioscapit... |
| - | Meneldor | meneldor.n... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 26.06.2023 | Series A | $65M | - |
Mentions in press and media 5
| Date | Title | Description |
| 26.06.2023 | Dutch-based Tagworks Pharmaceuticals raises €59.5M to design effective, safe systemic therapies | The Netherlands-based Tagworks Pharmaceuticals, a company that claims to be a pioneer of Click-to-Release chemistry to deliver effective and safer systemic therapies, announced on Thursday, June 22, that it has raised $65M (approximately €5... |
| 22.06.2023 | Ysios Capital lidera una inversión de $64M en Tagworks Pharmaceuticals junto con Gilde | 22/06/2023 Nota de prensa YSIOS CAPITAL LIDERA UNA INVERSIÓN DE $64M EN TAGWORKS PHARMACEUTICALS JUNTO CON GILDE Ysios Capital, gestora española líder en inversiones en el sector biotecnológico, ha anunciado hoy su participación en la ro... |
| 22.06.2023 | Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics | Financing round led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture Fund, New Enterprise Associates, and Lightstone Ventures Unique Click-to-Release platform enables on-target activation of antibody-drug conju... |
| 22.06.2023 | Tagworks Pharmaceuticals Raises $65M in Series A Financing | Tagworks Pharmaceuticals, a Nijmegen, Netherlands-based provider of a Click-to-Release chemistry designed to deliver effective and safe systemic therapies, raised $65M in Series A funding. The round was led by Ysios Capital and Gilde Health... |
| - | Tagworks Pharmaceuticals | “As pioneers of Click-to-Release technology, we are revolutionizing cancer treatment using in vivo click chemistry to increase the therapeutic window of powerful cancer therapies.” |